Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Name change and symbol also coming...
Any idea around when this may happen and could it be a pps game changer..?
FRZT up 87+%..? What gives..?
Looking forward to the 10-Q in May. $FRZT now has millions of dollars in revenue (more than it ever has) and the PPS will reflect that in the coming months.
Yep... It's coming...
Come on now.....California, Texas, Pennsylvania, Mass, Conn, NJ, NY, etc.
US Warranty, Capoli, Scully, others - They bring plenty of "friends" to the table.
Details of new deal with Midwest distributor on the way as well.
Global distributors. Global deals.
Checks/POs are starting to pile up.
Record revenues.
All positives. Again, PPS will soon reflect the real story here.
Yep...
This company is base in facts not intuition. It is true that JF have made several assumptions that have not come to fruition YET; however, VIVALIVETV, is a company that has a product that is in its infancy and better, you can subscribe to it and see its development as time passed by. Before, it has lots of channel with good to fair to poor + pics resolution, now ALL the channel can be seen HD-4K. OTTV owns its malware which has its own advantage like rent it to other companies and create revenues, Once the DVR, the movies, the premium channels, own your channel are running, maybe if they can sell all including internet I will see many people hitting their head in a wall, cause they did not took advantage of buying low. IMHO.
Yep...
$ONCI Solid month ahead with new contracts adding revenues and the size of contracts getting larger each month after.
Fins this month...look for new eyes here and new investors.
NEW TWEET: Huge meeting today with one of the largest dealer groups in the tri state area. Heading to Florida tomorrow for meetings with Ritter
$$$$$ ONCI $$$$$
Yeppers...
New pharmacy location's Parata PASS 500 dose packaging system has a capacity of 500 canisters at one time, which is worth about $280,000. PharmCo's current ScriptPro CRS 225 packaging system holds up to 225 individual medications and fills over 1000 prescriptions per day and costs about $200,000. These are great assets for Progressive.
Parata PASS 500
Yep...
$RXMD UPCOMING CATALYSTS / NEWS
February NET revenues: Week of March 12th or 19th or sooner - should be record net revenues again with possibly our second 2M+ month.
Acquisition details: With the latest announcement of the company's intent to purchase a pharmacy in Palm Beach County, we will see additional details around this purchase and what it means on the revenue side.
Audited Annual Report: Report is due 3/31 and will be the second audited year. Having two years of audited fins is the gold standard for institutional monies to flow in.
Conference call for shareholders: This occurs every quarter. Should happen around the release of the annual report.
March Numbers: Week of April 12th or 19th - should be record revenues again with possibly our third 2M+ month.
Additional technology partnerships / contracts: Progressive care is both a healthcare services and technology company. Expect additional PRs and contracts stating new revenues streams
Institutional buying: We've had what looks to be institutional buying recently and I would venture to guess we will receive more news about institutions covering us and major investments after we have our two years of audited financials in April.
Institutional stock coverage: Shital has made it clear that she'd like to have coverage of the stock by institutional analysts. We are seeing more and more signs of this and will hear more about it soon IMO.
Online Pharmacy / e-Commerce: With the news of Bitcoin and Amazon looking to get into the pharmacy space, expect additional news on RXMD about becoming a major online pharmacy.
CBD / MJ / HEMP: One of the latest major developments. Additional news about CBD and MJ will most likely be coming out in the next couple of months. They already stated they will have in-house compounding and R&D! This will boost sales big time as customers would like to see alternatives to addictive pain pills.
Tech / Tele-Pharm news: With the latest development of this being a tech play, we should hear more about their plan for tele-Pharmco and also we should hear from our NASDAQ independent board member on the latest developments.
Investor conferences to attract institutional investors: They will most likely PR these events over the coming months.
New 340B contracts: Over the next month or two we will most likely hear about new 340B contracts from multiple partners
New Long term care facility relationships: The company continues to be active in the community with doctors, patients and long term facilities. Expect additional partnerships on this front.
Achieve accreditation for non-sterile compounding: One the company's stated goals for 2018 is receiving accreditation for non-sterile compounding. This will actually allow them to make more money with more of a backing.
Traditional financing: Expect news of traditional financing over the coming year.
Opening more Pharmco Pharmacy Resource Centers in retirement and long term care communities: Another 2018 goal of the company. They will announce more resource centers to again strengthen their relationships in the community.
More out of state licenses: They've already obtained 14 state licenses where they can do business and planning to expand to more states. We may hear more about these revenue streams as they add to the bottom line.
Purdue sales rep team: We should be hearing more about the Purdue pharma sales force to join the team for conducting out of state sales
Expansion / M&A: We should be seeing additional PBM contracts related to their recent acquisition. I also believe we will hear more about additional acquisitions and other partnerships.
NASDAQ uplisting: With traditional financing, 2 locations and a much higher PPS, I expect to start to hear more about the company's plan to uplist to NASDAQ.
Yep...
Again, "fair market value" implies a fair market, which is not what we have at this point. Only a very small portion of the market even knows RXMD exists, much less about the impressive fundamentals that are now driving the share price up with or without news.
As I said, as more investors are becoming aware of RXMD, the share price begins to move towards a fair market value, but that won't happen today, and it won't be anywhere near 12 cents...
Yep... it always happens...
The green causes a disappearing act for complainers when they discovery how wrong they were... I don't miss them... do you..?
I predict increments of between 3 - 5 cents for RXMD pps each week going forward... We shall see...
Best fortunes to the RXMD faithful...
Correct! One of the things I have noticed here is the lack of downers that attack almost every single board at the Ihub. Lot's of positive posters here along with the many well capitalized long term investors that are clear examples of what can happen with a little patience and half a clue. I see no short's trying to manipulate this downward as we are obviously too strong and way too risky for even the best short traders. We will have down days going forward,like any healthy stock, but I believe we continue to make higher lows and higher high's going forward as long as we continue to progress. GLTY
Aloha Euripides90,
Sorry... don't have private but... yes I do believe there are multiple revenue streams for BVTK that will go stellar in the next 30 days or so... Hang in there my friend...
Makes perfect sense.
BVTK now current... All systems are go...
In Reply to 'Euripides90' on 'Bravatek Solutions Inc. (BVTK)
On plus-side, most-of-the-conversions-ALREADY-diluted-price, except under 100M or so in late December, so with Tom plugging away with his BFF Denis Leary of DarkPulse and all the stuff he's got going on, March 2018 should look a lot better... Look at all the steady support:
Upward MOMO will come for March-May to uplist. That's where Tom has always wanted to be.
This is why he raised the A/S, seems to have enough room there to avoid an R/S while he's working on other financing. Would be nice if he forgoes his own salary (around 200K) meanwhile in solidarity with shareholders, but he IS aiming for the BIG PRIZE AND WILL GET THERE...
Aloha Wallstreet & FRZT family...
I was waiting to get filled at .042 for some time and it wouldn't fill even though it was at the Ask. Do you think that means there wasn't enough shares to buy at that .042 pps..?
Also someone else had asked if there was a minimum share amount needed to purchase to effect the pps..?
You seemed like one of the more knowledgable members of the FRZT family, so I hope you respond. If you're not around today these inquiries go out to anyone here who may have the answers...
Thank you in advance...
eTrade posts on it's market caster that FRZT closed at .0396
Why is this not being reflected in the closing pps..?
Something not right about this...
Right you are my friend...
As a shareholder since May 2015 I haven’t sold a share and frankly we’ve been deserving of our current PPS for a couple of years now.
This is just the beginning of a strong story of growing business and going to NASDAQ.
I do not intend to sell anything and can easily see this trading dollars.
24M+ a year with every location they acquire.
This is screaming dollars.
One of the safest investments even over big board stocks IMO.
Yep...
$ONCI is making a lot of $$$$$ at this moment and growing day by day. In 2016 revenue $200K for ALL '16....
$ONCI going to have IN Q1 "March 15 2018" a revenue of + $1million and NET PROFIT with margins of +30%
So if people trying over here to say $ONCI is a bad company and NOT doing well !!!
Well we will find out where $ONCI will end... wink
What do you think of my educated guess now beer..?
In Reply to 'beerbuoy' on 'Progressive Care, Inc. (RXMD)
Wednesday, 02/28/18 10:37:54 AM
Quote:
Anybody care to make an educated guess as to RXMD pps by Friday..?
I'm gonna predict we break 10+ by Friday eod...
"[My educated guess is we break .12 by close on Friday]"
[With today's News... My new educated guess is we break .14 by close today..!]
We shall see...
Yep.. kinda feel sorry for drum...
Patience will pay... We shall see...
ONCI GOLD...
I think you've convinced yourself of that. Revs aren't produced out of thin air. It takes time, money, and a helluva lot of work to bring a new product to market. SB and team are working tirelessly to build a profitable company from the ground up.
Been trading pennies for over 20 years. I've seen many shams, and have been victim of them. I promised myself to do the DD before jumping in head first so this won't ever happen again.
As a Long Islander, I am familiar with the type-A personalities we breed here. SB is one of them, no doubt. And I know for sure that this type of personality might rub someone the wrong way. Does he exaggerate? No doubt. Is he a bit too much 'forward looking'? Sure. But is a con-man? I can assure you he is not. And I put my money where my mouth is on this.
THANK YOU WRENCH..!
CONVERSATION WITH ONCI CEO STEVE BERMAN 2/26/18
I managed to get in touch with ONCI CEO Steve Berman for a brief chat about some of the current questions that have come up of late. He was kind enough to take time out of his busy schedule (he was between meetings when we spoke) and shared as much info as he could in the time we had.
I want to preface this by saying that SB is a hardworking, passionate CEO who is working toward a goal of great success. This is the first time we've spoken at length and it made me realize that not only are we fortunate to have such a smart, savvy, articulate captain driving the ship, but we as shareholders (despite the countless hours of DD and gross assumptions we pour into ONCI), only the man and his team really know exactly what is happening behind the scenes. Hopefully some of what I report will clear things up.
PAST RELATIONSHIP WITH TXTM AND DRIVEALERTNOW
As we know, SB used to work for Protext Mobility (TXTM). Before Steve was on board, TXTM formed a licensing deal with DriveAlertNow to bring public awareness and a potential solution to the distracted driving epidemic. SB was then brought on board, as his years of marketing and sales experience seemed a natural fit to bring this 'solution' to the masses. However once SB began settling into his position, he came to realize that there were inherent problems, both with TXTM's dealings with DriveAlertNow and with the APP itself. The most complicated hurdle was that the software was programmed exclusively for android use, making it a very difficult sell. During this time, SB formed a relationship with Cogosense. and decided bringing them public through the ONCI shell made for a much better career opportunity. Three years ago he recognized the growing epidemic of distracted driving and wanted to be at the forefront in providing a solution. It was the right move given the immediate success he's found with Cogosense's products.
BIG AUTO
SB is still actively pursuing a deal with Big Auto. All previously discussed opportunities are still on the table and are being worked on. He said that working with such big corporate entities takes a great deal of time for various reasons, the biggest of which is the vetting of the technology. Each wants to see how this patented technology will best suit an integration into their own tech. Lofty requests have been made for changes, all of which are taking a lot of time and energy for Cogosense's programmers. BMW requested that the tech operate in 7 languages, for instance. This is no small feat. But it is being done. The opportunity is there and the timing is right to make something happen, and the ONCI team is doing everything they can to make it happen.
DEALERSHIPS
Sales to dealerships have been the immediate and most lucrative source of revenue for the company. SB saw this as his initial starting point for sales and has not let up for one moment. Not only have there been many 6 and 7-figure sales to dealerships, but he was quick to point out that retail sales have been VERY STRONG and that he is beginning to see increased orders and reorders. The dealerships LOVE the product, with many communicating details of the technology and its strong sales to their corporate HQ's. He's hopeful that their continued support will continue to bring further interest to Big Auto.
One thing he mentioned was that the managers of the some dealerships have complained about shareholder calls, some of which have been harassing in nature. This puts SB in a difficult spot, as he's trying to appease shareholders by being specific with names. However this is resulting in a strained relationship with SB and some of his clients. IMO--it's in our best interests as shareholders to keep our vetting to a professional level, if at all.
OTHER SALES
At this moment, ONCI has 37 independent sales reps with a clientele list suited for pitching our distracted driving technology to. This does NOT include any reps working for the (announced) distributors we hired: Capoli, US Warranty, Scully Lemoine, and Cataclean. These companies have units and literature and are currently 'pounding the pavement'. Of the 37 independent reps, ALL are commission based and YES, they are currently selling Bsafemobile to their accounts. The company is seeing many 'smaller' orders which SB noted are adding up. SB also noted that he's working with them toward an initial minimum goal of just 20 units per rep per month, which is a very plausible scenario. Think about it: that's over 8,000 units a year just in small orders. And this is a starting point.
SB also mentioned that there's a distributor in place with strong relationships with major retailers. He's very excited about this opportunity and sees this as a gateway to bring BsafeMobile to the mass market.
AMAZON
As we know there is a 3P seller on Amazon selling Bsafemobile. He is a former dealership employee who had a few units in his possession when he left his position. SB cannot list Bsafemobile as he will need to match this person’s pricing and cannot do that as he is vigilant in maintaining the integrity of the retail price in the marketplace. SB has purchased three units from this person himself and feels his supply is nearly exhausted. Once this person is out of stock, ONCI will begin selling on Amazon with an already-in-place promotional push from FLY.
LAW OFFICE
The Florida law office represents over 250 dealerships and has been actively taking orders for Bsafemobile. SB said the venture is a strong one and with continued support of the firm, monthly revenues will continue.
DENTAL
Currently exploring various non-dilutive funding opportunities to close on the acquisition, and begin rolling out the mobile-care business. He noted that most of the company's current income is being used to further develop the bread-winning Cogosense division of the business at this time.
MJ
Vetting companies as I write this. Issue is many businesses are not fully and properly licensed for all aspects of the business he is trying to establish.
T-TRADES & DILUTION
I asked specifically about dilution and he stated yet again to me that up until recently there has only been dilution to satisfy the LAM debt, which was reported on the annual. Since then, there has been VERY LITTLE dilution, which is being used solely for operating expenses, such as commission payments to the reps and legal fees.
As for T-trades, he said that in this instance we are seeing trades from a specific brokerage (I did not write it down and cannot recall which one it was) that are taking large buy orders from clients requesting a specific price. This large HUB brokerage then sends the order out to their smaller satellite or SPOKE brokerages that then record the buy and send back into the main ‘HUB’. The main HUB accumulates all the small orders from the smaller satellites and prints it as one large trade, or T-Trade at the end of the day. He assured me that despite all the crazy theories being touted, that he has nothing to do with the large T-Trades and that the dilution is minimal.
HEXAGON/DE/AUDIT
The $25,000 question. SB told me what he could and definitely cleared up any concerns I had. YES, the audit will happen. YES we will be Hexagon. YES DE debt will be cleared. Although the DE debt exists, it is MUCH LOWER than anyone knows or assumes it to be. SB feels that the former owners should be responsible for settling it and is legally pursuing this avenue. He said the total DE debt will be revealed on the 3/15 Q1 and again, will be MUCH lower than anyone thinks. But this is only ONE of the issues affecting the audit.
When MAZARS (He reiterated that it’s a 100% bona-fide a REAL letter) started the audit, there was the necessity of obtaining various legal documents from the former shell owners. All of which the owners are hesitating to provide due to the fact that they would accrue a variety of costs and expenses, including responsibility for the now infamous DE debt. Again, SB is legally pursuing this matter and will not let up until MAZARS is satisfied. Once the issues with the former owners and DE is fulfilled, MAZARS can complete the audit and ONCI can become HEXAGON.
That’s all we had time for but I think it clears up a good portion of what we are concerned about. On closing, despite the hours of DD I’ve put into researching ONCI, I was filled in on a LOT of info I did not know. Keep this in mind when others tout details they could not possibly know without being a part of the company.
SB is a very smart, aggressive Long Islander with an undying passion for building his business. At the end of the day, he’s the one you want running this company.
GLTA
Funny how the complainers disappear into the green...
Excellent day for RXMD everyone..!
Let's get through 11 and 12 tomorrow..!
Wow... through 10 sooner than expected... next stop 11, 12, 15...
Always, always, always set a high price when you post sell order on RXMD after you buy..!
My sell price is $2.88 for 2018.
In Reply to 'stockforce' on 'Progressive Care, Inc. (RXMD)
RXMD IS THE REAL GEM. This stock has been severely undervalued for years due to several reasons:
1. Progressive restructured its management team back in Jan. 2013 and got engaged in a 3(a)10 transaction for debt settlement in 2014, which helped them successfully pay off all the debt in Nov. 2015. They actually already had tremendous amount of revenues in those three years with double digit growth:
2013 net revenue: $9.33M
2014 net revenue: $11.27M
2015 net revenue: $13.64M
2. They completed their first audited financials of 2016 in April 2017. For the whole year of 2016, The stock price never surpassed 5 cents due to lack of audit and insufficient exposure to mass investors. See more DD of RXMD from INSTATRADER here:
https://investorshub.advfn.com/INSTATRADERS-LONG-TERM-OTC-WINNERS!!!!-32023/
3. The company started devoting more time and money on investors conferences and PR companies in 2017 after they made enormous achievements in their 2016 and 2017 revenue growth:
2015 net revenue: $13.64M
2016 net revenue: $18.32M
2017 net revenue: $20.1M
However, as the management said, institutional money would not start investing until they see at least 2 years of audits. The stock was still mostly unknown to mass investors at that time.
One of the biggest things the company is doing right now is to complete a second year audit of 2017. This is definitely a big GO for institutions and private equities, who normally have great investing interest in companies that have at least $20M revenue. The past week's price action was a clear indication to me that some institutional money started getting in with constant ask slaps and strong bid supports that were worth several million dollars.
Some other exciting things to expect this year, most likely within next several months are:
One or two M&A as a vehicle to help the company eventually uplist to NASDAQ. In CEO's own words from Uptick Newswire's interview on Feb 1, 2018:
Question - "Are you guys thinking about moving up to the NASDAQ?"
CEO, Shital Mars: "Yes. So the ultimate goal has always been to become fully SEC reporting and list on NASDAQ. We think that is the right place and right path for us to go. And we think healthcare is ripe for that change and we think there’s a lot of competition and opportunity in the marketplace for a company like ours to create something special and unique and worthy of being on NASDAQ. We also know that we want to have the right vehicle for it. So it’s not something we want to do just as we are today. We want to evolve into that NASDAQ worthy company, and we are putting all the staff in place, all the factors, all the personnel and resources in place right now to get us to there as our end goal."
Entry into CBD/Hemp Market
Acquiring additional 12 out-of-state licenses, which will make them obtain a total 29 state licenses in the U.S. by EOY.
The following are our strategic goals for 2018:
Achieve 25,000 prescriptions filled in a single month by December 2018
Increase annual overall sales to $22 million
Secure additional 340B contracts and long term care facility relationships
Further expansion into Palm Beach County
Achieve accreditation for non-sterile compounding
Achieve full enterprise profitability and earnings growth
Publish 2nd year of audited financial statements and leverage these statements to secure new investment opportunities for mergers and acquisitions
Opening more Pharmco Pharmacy Resource Centers in retirement and long term care communities.
Strengthening our tele-pharmacy platform
Closing Remarks
The strength of Progressive Care has always been in the hands of its employees and its shareholders. Without the loyalty and dedication of both, this Company would not be where it is today. We have thrived because of the unyielding support in the face of immense challenges and we know that we must never waver in our desire to always earn the trust that has been bestowed upon us. Thank you to all who believe in us and we look forward to delivering another phenomenal year.
Just for your fun reading, I have compiled a short version of Progressive's long history since its inception in 2006 and even before that all the way to 1997. This company is indeed a GEM that has just been noticed by BIG money. Get in now and we will witness how this stock will make its way all the way to NASDAQ.
A short version of ProgressiveCare's long history:
Everything started from a person called Buddy Young. He founded a publicly traded company called Web Star Training in 1997, engaging in the development, production, and distribution of training and educational video products and services. The company then changed its name to Advanced Knowledge, Inc. in 2000; and to Advanced Media, Inc. in 2003. Later, the company changed its name to Advanced Media Training, Inc. in 2004. Advanced Media Training is based in Encino, California. As of December 11, 2006, Advanced Media Training, Inc. was acquired by Dematco Corporation, a private UK company, in a reverse merger.
Progressive Training Inc. was incorporated by Mr. Young in Delaware on October 31, 2006. From the date it was incorporated until March 1, 2007, it was a wholly owned subsidiary of Dematco, Inc. On March 1, 2007, to facilitate Dematco's exit from the training business, Progressive Training acquired all of Dematco's assets and liabilities related to the production and distribution of workforce training videos.
In 2006, another person, Avraham A. Friedman, together with two partners, founded Pharmco in Florida. Mr. Friedman started in 1996 at the clerk level and after 4 years in 2000 became retail manager for a busy New York City independent pharmacy. He then left New York for Florida and started Pharmco in 2006.
Then, on October 21, 2010, Progressive Training, Inc. entered into an Agreement and Plan of Reverse Merger with Pharmco Corp. Upon the closing of the Exchange, Buddy Young resigned as the Company’s sole officer and director and David Leedy, Dennis Spiegelman and Mel Powell resigned from their positions as members of the Company’s board of directors. Simultaneously with the effectiveness of the Merger a new board of directors and new officers were appointed. The new board of directors consists of Avraham A. Friedman, Andy Subachan and Alan Jay Weisberg. Avraham A. Friedman was appointed as the Company’s Chief Executive Officer and President. Andy Subachan was appointed as the Company’s Chief Operating Officer. Alan Jay Weisberg was appointed as our Chief Financial Officer.
Mr. Weisberg is a Certified Public Accountant and currently operates Weisberg Brause & Co. Mr. Weisberg served as chief financial officer and as a director of QuickByte Software, Inc., from July 2008 to July 14, 2009. He served as chief financial officer and as a director of Getting Ready Corporation, Inc. from September 2007 through September 2008. From April 1998 through December 2006, Mr. Weisberg served as chief financial officer and as a director of Orthodontix, Inc. In addition, Mr. Weisberg served as chief financial officer and as a director of Protalix Biotehrapeutics, Inc. from December 2006 through April 2007. Mr. Weisberg also serves as a member of the board of directors and as secretary of Protech Global Holdings Corp. (“Protech”) Mr. Weisberg also previously served as chief financial officer of Protech.
On November 24, 2010, Progressive Training, Inc. (the “Company”) filed a Certificate of Ownership and Merger, pursuant to which its wholly-owned subsidiary, Progressive Care Inc. was merged into and with the Company (the “Merger”). In connection with the Merger, the Company changed its name to “Progressive Care Inc.”
Effective January 1, 2011, Mr. Young's another company, Futura Pictures, Inc. acquired from Progressive Training, Inc. all of its assets and liabilities related to Progressive’s workforce training business. On February 27, 2015, Mr. Young sold Futura Pictures to some South Korean guys and the company's name was changed to IMK Group, Inc.
On March 23, 2012, Progressive's CEO Avraham Friedman, issued his inaugural annual letter to the shareholders. The letter outlined Progressive Care's accomplishments in 2011 as well as its strategic goals and initiatives for 2012. Some highlights included hiring world renowned recording artist Luther Campbell as a company spokesperson. Mr. Campbell is deeply involved in the company's community outreach program and in the development of our anti-retroviral patient management program. Mr. Campbell's work will also be in combination with the new initiative planned by Progressive Care and PharmCo's HIV/AIDS Action Committee headed by Mrs. McDonald, a former Florida Department of Health Program Manager. They also have begun delivering with their fleet of visually branded delivery vehicles delivering to all of South Florida. The fleet is part of a marketing effort to enhance visibility of PharmCo in South Florida. They also signed an LOI to acquire an independent pharmacy in Coral Springs, FL.
On April 30, 2012, Progressive Care entered into the Equity Agreement with TCA. TCA committed to purchase up to $2,000,000 of the Company’s common stock for a period of twenty-four (24) months.
On August 30, 2012, Progressive Care announced that it has hired Mr. Vernon Watson as Chief Executive Officer and Ms. Shital Parikh Mars as Chief Operating Officer, effective August 27, 2012. Ms. Parikh was also appointed to the Board of Directors of Progressive Care at meeting held on August 24, 2012. Mr. Avraham Friedman, the Company’s former CEO, remained Chairman of the Board and assumed the role as the Company’s Chief Compliance Officer.
Mr. Watson was a Regional Sales Manager for MOMS Pharmacy in Melville, New York before joining Progressive. He helped increase the company’s sales and market share from New York to the tri-state area and Florida.
Ms. Parikh has been a vital consultant to the Company for the past three years (2009 - 2012). As President and CEO of Spark Financial Consulting, Ms. Parikh provided business development consulting services in which she advised the Company on human resources, financial reporting and transactions, operations, compliance, SEC filings, and investor relations, among other things. Ms. Parikh was also the Chief Operating Officer of Basis Financial, a boutique investment banking firm engaged by the Company. Her experience in the financial services industry centers on operational management, preparation and submission of financial statements, mergers & acquisitions, securities offerings, SEC reporting, due diligence, compliance, and regulatory audits. Ms. Parikh currently maintains 8 securities license registrations including the Series 7, Series 66, and Series 24.
On, January 17, 2013, Mr. Vernon Watson resigned from his position as the Chief Executive Officer of Progressive Care, Inc. after only five months with the company. His own words in the resignation letter: "Please accept this letter as my two-week notice of resignation. My last day of work will be Jan 25 th , 2013. It's been a wonderful 5 month experience working with Progressive Care. I have decided to relocate back to New York. I have enjoyed working with each and every one of you and appreciate the opportunities I've been given. I will do my best to hand off any current appointments prior to my last day of work. Please let me know if you need my help in any other way."
On January 21, 2013, Mr. Avraham Friedman resigned from his position as Chairman of the Board of Directors (the “Board”) of the Company. His own words in the resignation letter: "I thank each and every one of you for the opportunity to sit as Chairman of the Board. Regrettably, I must resign my position as Chairman of the Board effective immediately. I will, however, continue to retain my position as Chief Compliance Officer and look forward to working together to improve and grow Progressive Care. I thank you."
On January 22, 2013, the Board approved by unanimous written consent the appointment of Mr. Alan Jay Weisberg as the Company’s Interim Chief Executive Officer and Chairman of the Board. Mr. Weisberg has been a member of the Board and has served as Chief Financial Officer of the Company since October 2010.
On February 5, 2013, Mr. Avraham Friedman resigned from his position as Chief Compliance Officer of Progressive Care Inc. (the “Company”). In connection with Mr. Friedman’s resignation, the Company provided severance payment in the form of one half of Mr. Friedman’s current salary and one half of the premiums for Mr. Friedman’s insurance policy for a period of twenty-four weeks. His resignation letter:"This letter shall serve as notice that effective immediately, I hereby resign from my position as Chief Compliance Officer with Progressive Care, Inc. (the "Company", and all other positions to which I have been assigned, regardless of whether I served in such capacity, of the Company. The resignation is not the result of any disagreement with the Company on any matter relating to the Company's operations, policies or practices. Sincerely."
On May 17, 2013, the board of directors of Progressive Care, Inc. dismissed Berman & Co., P.A., as the Company’s independent registered public accounting firm. On the same day, the board approved the engagement of Mallah Furman, Certified Public Accountants (“Mallah”), as the Company’s new independent registered public accounting firm.
On September 3, 2014, the Circuit Court of the Second Judicial Circuit for Leon County, Florida approved the 3(a)(10) transaction between Progressive Care and Tarpon Bay Partners. Progressive and Tarpon reasonably estimated that the fair market value of the Settlement Shares, the Fee Shares (as defined below) and all other amounts received or to be received by Tarpon is equal to approximately $2,434,673.00.
On March 18, 2015, Progressive terminated 12g with SEC.
On Dec 29, 2014, COO, Shital Mars released an open letter to Shareholders. Highlights of 2014:
Agreement and court approval to execute a 3(a)(10) transaction through Tarpon Bay Partners, LLC to eliminate $1.8 million in debt in the coming year
Filed unaudited financial statements with OTCMarkets through the most recent completed quarter
Restructured Management
Aggressively cut costs
Began a hiring program to recruit talent and meet growing demand
Renovated our PhamCo facility
Increased filled prescription counts by approx. 50% from 8,500 scripts per month to almost 13,000
Increased pharmacy sales by 35% to $8.1 million through September 30, 2014
The strategic goals for 2015:
Increase filled prescription counts to 20,000 per month by December 2015
Increase annual overall sales to $15 million
Achieve full enterprise profitability
Eliminate approximately $1.8 million in debt from the balance sheet
Merge, acquire or otherwise align ourselves with a synergistic independent pharmacy to create economies of scale
On November 10, 2015, Progressive announced the fourth consecutive quarters of profitability for PharmCo, LLC. Through the first nine months of 2015, PharmCo, LLC has recorded nearly $350,000 in net income. This is a significant turnaround when compared to net losses of $114,000 for PharmCo during the same time period in 2014. PharmCo has recorded profits in every quarter for the past 12 months. Profitability and positive cash flow in PharmCo has been achieved through concentrated marketing efforts, expansion of the compounded medication department and month over month of net increases in prescription sales. Progressive Care's consolidated income was nearly break even in the third quarter when adjusted for stock based compensation of $147,000.
Due to dramatic increases in demand, PharmCo initiated plans to expand the pharmacy this quarter. The facility currently fills approximately 50,000 prescriptions per quarter with minimal square footage devoted to compounding and long term care operations. The expansion plan would nearly double the amount of general filling space plus expand the compounding department. The company also is in the process of choosing and purchasing a robotic dispensing system. This system will allow PharmCo to tremendously increase production and save on labor cost. To take advantage of its marketing capabilities the company plans to expand to Palm Beach County. PharmCo expects the expansion to produce numerous positive results including improvements to efficiency and capacity as well as increased revenues.
Recently, PharmCo began the process of establishing 340B sales. Both PharmCo and its 340B provider are installing the vendor data necessary to start purchasing inventory for 340B patients. The Company anticipates that we will be realizing sales in this area before the end of the year. PharmCo is also quickly increasing its footprint in the Medication Therapy Management (MTM) industry. On a monthly basis, the company is seeing increases in the number of MTM cases provided by Medicare plans. While the company does not expect a material impact on this year's sales from MTM cases, MTM will be an important part of the business in 2016.
On December 10, 2015, Progressive announced that it has completed its 3(a)(10) transaction. In total the company has issued 282,275,000 shares of common stock to eliminate over $1.9 million in aged debt off of its balance sheet. The company estimates that of these shares approximately 12,000,000 shares will be returned to treasury.
As of December 9, 2015, total common stock issued and outstanding was 352,043,045 shares. This number is net of a 1,718,000 share adjustment as these shares are beneficially owned by the company through PharmCo, LLC. The total number of shares that are not beneficially owned by insiders or affiliates was 306,833,938.
On Dec 14, 2015, Progressive announced record November pharmacy revenues. The pharmacy filled approximately 15,000 prescriptions during the month of November, which is nearly a 30% increase over the same month last year. Historically, due to the open enrollment window, physicians undergo major changes to their patient base resulting decreases in prescriptions written. However, PharmCo grossed approximately $1.3 million in net revenues for the month despite the lower prescription count. The compounding department continues to drive strong revenue growth.
In the week of Jan. 4, 2016, Progressive will issue 2016 Open Letter to shareholders.
In October, 2017, Progressive uplisted to OTCQB.
In Jan 2018, Progressive announced over $20M NET REVENUE for 2017.
In Feb 2018, Progressive announced all-time-high single month revenue of $2.25M and 23,000 prescription fills.
To be continued...
$ $RXMD
Yep...
At the very least, there should be news in March, 2018 about health and fitness Corp. partnerships.
Update from CEO Craig Holland dated 1/11/18:
The company also reported progress in the areas of corporate partnerships and product development:
Corporate partnerships – The company is negotiating with several organizations to promote Freeze Tag products such as Munzee®, Garfield Go and ZeeTours™ for health and fitness. Announcements about specific partner organizations will be announced in Q1 2018.
ZeeTours – Initial sales of ZeeTours products have been very encouraging. Additional ZeeTours in cities across the USA are being developed and will be launched through promotional partner Groupon in the near future. Products like ZeeTours typically become very popular in the spring and summer as more people enjoy outside activities.
Munzee (the global scavenger hunt game) - The product development process for a “new and improved” Munzee app is underway. The company will be providing more details on the Munzee product roll out process in the coming months.
Long and holding so far.
Yep... Marching forward with OTTV...
VIVA Tweet
Quote:
Viva working out a deal with the Winter Film Awards to gain access of their movie library. Viva brand present at the Winter Film Awards this Saturday in NYC.
10:31 AM - 28 Feb 2018
Done deal?
https://www.instagram.com/p/Bfra6m3HRcx/
Yep... Let's break that 10...
No matter the size of your Buy... Hit the ASK... hard...
Do it today folks...
Always, always, always set a high price when you post sell order on RXMD after you buy..!
My sell price is $2.88 for 2018.
In Reply to 'stockforce' on 'Progressive Care, Inc. (RXMD)
RXMD IS THE REAL GEM. This stock has been severely undervalued for years due to several reasons:
1. Progressive restructured its management team back in Jan. 2013 and got engaged in a 3(a)10 transaction for debt settlement in 2014, which helped them successfully pay off all the debt in Nov. 2015. They actually already had tremendous amount of revenues in those three years with double digit growth:
2013 net revenue: $9.33M
2014 net revenue: $11.27M
2015 net revenue: $13.64M
2. They completed their first audited financials of 2016 in April 2017. For the whole year of 2016, The stock price never surpassed 5 cents due to lack of audit and insufficient exposure to mass investors. See more DD of RXMD from INSTATRADER here:
https://investorshub.advfn.com/INSTATRADERS-LONG-TERM-OTC-WINNERS!!!!-32023/
3. The company started devoting more time and money on investors conferences and PR companies in 2017 after they made enormous achievements in their 2016 and 2017 revenue growth:
2015 net revenue: $13.64M
2016 net revenue: $18.32M
2017 net revenue: $20.1M
However, as the management said, institutional money would not start investing until they see at least 2 years of audits. The stock was still mostly unknown to mass investors at that time.
One of the biggest things the company is doing right now is to complete a second year audit of 2017. This is definitely a big GO for institutions and private equities, who normally have great investing interest in companies that have at least $20M revenue. The past week's price action was a clear indication to me that some institutional money started getting in with constant ask slaps and strong bid supports that were worth several million dollars.
Some other exciting things to expect this year, most likely within next several months are:
One or two M&A as a vehicle to help the company eventually uplist to NASDAQ. In CEO's own words from Uptick Newswire's interview on Feb 1, 2018:
Question - "Are you guys thinking about moving up to the NASDAQ?"
CEO, Shital Mars: "Yes. So the ultimate goal has always been to become fully SEC reporting and list on NASDAQ. We think that is the right place and right path for us to go. And we think healthcare is ripe for that change and we think there’s a lot of competition and opportunity in the marketplace for a company like ours to create something special and unique and worthy of being on NASDAQ. We also know that we want to have the right vehicle for it. So it’s not something we want to do just as we are today. We want to evolve into that NASDAQ worthy company, and we are putting all the staff in place, all the factors, all the personnel and resources in place right now to get us to there as our end goal."
Entry into CBD/Hemp Market
Acquiring additional 12 out-of-state licenses, which will make them obtain a total 29 state licenses in the U.S. by EOY.
The following are our strategic goals for 2018:
Achieve 25,000 prescriptions filled in a single month by December 2018
Increase annual overall sales to $22 million
Secure additional 340B contracts and long term care facility relationships
Further expansion into Palm Beach County
Achieve accreditation for non-sterile compounding
Achieve full enterprise profitability and earnings growth
Publish 2nd year of audited financial statements and leverage these statements to secure new investment opportunities for mergers and acquisitions
Opening more Pharmco Pharmacy Resource Centers in retirement and long term care communities.
Strengthening our tele-pharmacy platform
Closing Remarks
The strength of Progressive Care has always been in the hands of its employees and its shareholders. Without the loyalty and dedication of both, this Company would not be where it is today. We have thrived because of the unyielding support in the face of immense challenges and we know that we must never waver in our desire to always earn the trust that has been bestowed upon us. Thank you to all who believe in us and we look forward to delivering another phenomenal year.
Just for your fun reading, I have compiled a short version of Progressive's long history since its inception in 2006 and even before that all the way to 1997. This company is indeed a GEM that has just been noticed by BIG money. Get in now and we will witness how this stock will make its way all the way to NASDAQ.
A short version of ProgressiveCare's long history:
Everything started from a person called Buddy Young. He founded a publicly traded company called Web Star Training in 1997, engaging in the development, production, and distribution of training and educational video products and services. The company then changed its name to Advanced Knowledge, Inc. in 2000; and to Advanced Media, Inc. in 2003. Later, the company changed its name to Advanced Media Training, Inc. in 2004. Advanced Media Training is based in Encino, California. As of December 11, 2006, Advanced Media Training, Inc. was acquired by Dematco Corporation, a private UK company, in a reverse merger.
Progressive Training Inc. was incorporated by Mr. Young in Delaware on October 31, 2006. From the date it was incorporated until March 1, 2007, it was a wholly owned subsidiary of Dematco, Inc. On March 1, 2007, to facilitate Dematco's exit from the training business, Progressive Training acquired all of Dematco's assets and liabilities related to the production and distribution of workforce training videos.
In 2006, another person, Avraham A. Friedman, together with two partners, founded Pharmco in Florida. Mr. Friedman started in 1996 at the clerk level and after 4 years in 2000 became retail manager for a busy New York City independent pharmacy. He then left New York for Florida and started Pharmco in 2006.
Then, on October 21, 2010, Progressive Training, Inc. entered into an Agreement and Plan of Reverse Merger with Pharmco Corp. Upon the closing of the Exchange, Buddy Young resigned as the Company’s sole officer and director and David Leedy, Dennis Spiegelman and Mel Powell resigned from their positions as members of the Company’s board of directors. Simultaneously with the effectiveness of the Merger a new board of directors and new officers were appointed. The new board of directors consists of Avraham A. Friedman, Andy Subachan and Alan Jay Weisberg. Avraham A. Friedman was appointed as the Company’s Chief Executive Officer and President. Andy Subachan was appointed as the Company’s Chief Operating Officer. Alan Jay Weisberg was appointed as our Chief Financial Officer.
Mr. Weisberg is a Certified Public Accountant and currently operates Weisberg Brause & Co. Mr. Weisberg served as chief financial officer and as a director of QuickByte Software, Inc., from July 2008 to July 14, 2009. He served as chief financial officer and as a director of Getting Ready Corporation, Inc. from September 2007 through September 2008. From April 1998 through December 2006, Mr. Weisberg served as chief financial officer and as a director of Orthodontix, Inc. In addition, Mr. Weisberg served as chief financial officer and as a director of Protalix Biotehrapeutics, Inc. from December 2006 through April 2007. Mr. Weisberg also serves as a member of the board of directors and as secretary of Protech Global Holdings Corp. (“Protech”) Mr. Weisberg also previously served as chief financial officer of Protech.
On November 24, 2010, Progressive Training, Inc. (the “Company”) filed a Certificate of Ownership and Merger, pursuant to which its wholly-owned subsidiary, Progressive Care Inc. was merged into and with the Company (the “Merger”). In connection with the Merger, the Company changed its name to “Progressive Care Inc.”
Effective January 1, 2011, Mr. Young's another company, Futura Pictures, Inc. acquired from Progressive Training, Inc. all of its assets and liabilities related to Progressive’s workforce training business. On February 27, 2015, Mr. Young sold Futura Pictures to some South Korean guys and the company's name was changed to IMK Group, Inc.
On March 23, 2012, Progressive's CEO Avraham Friedman, issued his inaugural annual letter to the shareholders. The letter outlined Progressive Care's accomplishments in 2011 as well as its strategic goals and initiatives for 2012. Some highlights included hiring world renowned recording artist Luther Campbell as a company spokesperson. Mr. Campbell is deeply involved in the company's community outreach program and in the development of our anti-retroviral patient management program. Mr. Campbell's work will also be in combination with the new initiative planned by Progressive Care and PharmCo's HIV/AIDS Action Committee headed by Mrs. McDonald, a former Florida Department of Health Program Manager. They also have begun delivering with their fleet of visually branded delivery vehicles delivering to all of South Florida. The fleet is part of a marketing effort to enhance visibility of PharmCo in South Florida. They also signed an LOI to acquire an independent pharmacy in Coral Springs, FL.
On April 30, 2012, Progressive Care entered into the Equity Agreement with TCA. TCA committed to purchase up to $2,000,000 of the Company’s common stock for a period of twenty-four (24) months.
On August 30, 2012, Progressive Care announced that it has hired Mr. Vernon Watson as Chief Executive Officer and Ms. Shital Parikh Mars as Chief Operating Officer, effective August 27, 2012. Ms. Parikh was also appointed to the Board of Directors of Progressive Care at meeting held on August 24, 2012. Mr. Avraham Friedman, the Company’s former CEO, remained Chairman of the Board and assumed the role as the Company’s Chief Compliance Officer.
Mr. Watson was a Regional Sales Manager for MOMS Pharmacy in Melville, New York before joining Progressive. He helped increase the company’s sales and market share from New York to the tri-state area and Florida.
Ms. Parikh has been a vital consultant to the Company for the past three years (2009 - 2012). As President and CEO of Spark Financial Consulting, Ms. Parikh provided business development consulting services in which she advised the Company on human resources, financial reporting and transactions, operations, compliance, SEC filings, and investor relations, among other things. Ms. Parikh was also the Chief Operating Officer of Basis Financial, a boutique investment banking firm engaged by the Company. Her experience in the financial services industry centers on operational management, preparation and submission of financial statements, mergers & acquisitions, securities offerings, SEC reporting, due diligence, compliance, and regulatory audits. Ms. Parikh currently maintains 8 securities license registrations including the Series 7, Series 66, and Series 24.
On, January 17, 2013, Mr. Vernon Watson resigned from his position as the Chief Executive Officer of Progressive Care, Inc. after only five months with the company. His own words in the resignation letter: "Please accept this letter as my two-week notice of resignation. My last day of work will be Jan 25 th , 2013. It's been a wonderful 5 month experience working with Progressive Care. I have decided to relocate back to New York. I have enjoyed working with each and every one of you and appreciate the opportunities I've been given. I will do my best to hand off any current appointments prior to my last day of work. Please let me know if you need my help in any other way."
On January 21, 2013, Mr. Avraham Friedman resigned from his position as Chairman of the Board of Directors (the “Board”) of the Company. His own words in the resignation letter: "I thank each and every one of you for the opportunity to sit as Chairman of the Board. Regrettably, I must resign my position as Chairman of the Board effective immediately. I will, however, continue to retain my position as Chief Compliance Officer and look forward to working together to improve and grow Progressive Care. I thank you."
On January 22, 2013, the Board approved by unanimous written consent the appointment of Mr. Alan Jay Weisberg as the Company’s Interim Chief Executive Officer and Chairman of the Board. Mr. Weisberg has been a member of the Board and has served as Chief Financial Officer of the Company since October 2010.
On February 5, 2013, Mr. Avraham Friedman resigned from his position as Chief Compliance Officer of Progressive Care Inc. (the “Company”). In connection with Mr. Friedman’s resignation, the Company provided severance payment in the form of one half of Mr. Friedman’s current salary and one half of the premiums for Mr. Friedman’s insurance policy for a period of twenty-four weeks. His resignation letter:"This letter shall serve as notice that effective immediately, I hereby resign from my position as Chief Compliance Officer with Progressive Care, Inc. (the "Company", and all other positions to which I have been assigned, regardless of whether I served in such capacity, of the Company. The resignation is not the result of any disagreement with the Company on any matter relating to the Company's operations, policies or practices. Sincerely."
On May 17, 2013, the board of directors of Progressive Care, Inc. dismissed Berman & Co., P.A., as the Company’s independent registered public accounting firm. On the same day, the board approved the engagement of Mallah Furman, Certified Public Accountants (“Mallah”), as the Company’s new independent registered public accounting firm.
On September 3, 2014, the Circuit Court of the Second Judicial Circuit for Leon County, Florida approved the 3(a)(10) transaction between Progressive Care and Tarpon Bay Partners. Progressive and Tarpon reasonably estimated that the fair market value of the Settlement Shares, the Fee Shares (as defined below) and all other amounts received or to be received by Tarpon is equal to approximately $2,434,673.00.
On March 18, 2015, Progressive terminated 12g with SEC.
On Dec 29, 2014, COO, Shital Mars released an open letter to Shareholders. Highlights of 2014:
Agreement and court approval to execute a 3(a)(10) transaction through Tarpon Bay Partners, LLC to eliminate $1.8 million in debt in the coming year
Filed unaudited financial statements with OTCMarkets through the most recent completed quarter
Restructured Management
Aggressively cut costs
Began a hiring program to recruit talent and meet growing demand
Renovated our PhamCo facility
Increased filled prescription counts by approx. 50% from 8,500 scripts per month to almost 13,000
Increased pharmacy sales by 35% to $8.1 million through September 30, 2014
The strategic goals for 2015:
Increase filled prescription counts to 20,000 per month by December 2015
Increase annual overall sales to $15 million
Achieve full enterprise profitability
Eliminate approximately $1.8 million in debt from the balance sheet
Merge, acquire or otherwise align ourselves with a synergistic independent pharmacy to create economies of scale
On November 10, 2015, Progressive announced the fourth consecutive quarters of profitability for PharmCo, LLC. Through the first nine months of 2015, PharmCo, LLC has recorded nearly $350,000 in net income. This is a significant turnaround when compared to net losses of $114,000 for PharmCo during the same time period in 2014. PharmCo has recorded profits in every quarter for the past 12 months. Profitability and positive cash flow in PharmCo has been achieved through concentrated marketing efforts, expansion of the compounded medication department and month over month of net increases in prescription sales. Progressive Care's consolidated income was nearly break even in the third quarter when adjusted for stock based compensation of $147,000.
Due to dramatic increases in demand, PharmCo initiated plans to expand the pharmacy this quarter. The facility currently fills approximately 50,000 prescriptions per quarter with minimal square footage devoted to compounding and long term care operations. The expansion plan would nearly double the amount of general filling space plus expand the compounding department. The company also is in the process of choosing and purchasing a robotic dispensing system. This system will allow PharmCo to tremendously increase production and save on labor cost. To take advantage of its marketing capabilities the company plans to expand to Palm Beach County. PharmCo expects the expansion to produce numerous positive results including improvements to efficiency and capacity as well as increased revenues.
Recently, PharmCo began the process of establishing 340B sales. Both PharmCo and its 340B provider are installing the vendor data necessary to start purchasing inventory for 340B patients. The Company anticipates that we will be realizing sales in this area before the end of the year. PharmCo is also quickly increasing its footprint in the Medication Therapy Management (MTM) industry. On a monthly basis, the company is seeing increases in the number of MTM cases provided by Medicare plans. While the company does not expect a material impact on this year's sales from MTM cases, MTM will be an important part of the business in 2016.
On December 10, 2015, Progressive announced that it has completed its 3(a)(10) transaction. In total the company has issued 282,275,000 shares of common stock to eliminate over $1.9 million in aged debt off of its balance sheet. The company estimates that of these shares approximately 12,000,000 shares will be returned to treasury.
As of December 9, 2015, total common stock issued and outstanding was 352,043,045 shares. This number is net of a 1,718,000 share adjustment as these shares are beneficially owned by the company through PharmCo, LLC. The total number of shares that are not beneficially owned by insiders or affiliates was 306,833,938.
On Dec 14, 2015, Progressive announced record November pharmacy revenues. The pharmacy filled approximately 15,000 prescriptions during the month of November, which is nearly a 30% increase over the same month last year. Historically, due to the open enrollment window, physicians undergo major changes to their patient base resulting decreases in prescriptions written. However, PharmCo grossed approximately $1.3 million in net revenues for the month despite the lower prescription count. The compounding department continues to drive strong revenue growth.
In the week of Jan. 4, 2016, Progressive will issue 2016 Open Letter to shareholders.
In October, 2017, Progressive uplisted to OTCQB.
In Jan 2018, Progressive announced over $20M NET REVENUE for 2017.
In Feb 2018, Progressive announced all-time-high single month revenue of $2.25M and 23,000 prescription fills.
To be continued...
$ $RXMD
Yep... Filter out the negative nonsense and consider IHub's ignore feature... Ah... what a relief it is...
Uh.. no.. quite the opposite. Misinformation is the opposite of proof.
REAL INFORMATION MATTERS! SUCH AS THIS:
Companies named in deals signed by Steve Berman have been confirmed to be offering BSAFEMOBILE and working with $ONCI under a signed contract.
Cogosense works as a subsidiary of On4 Communications.
More deals coming!
#SIGNINGDEALS #RECORDREVENUE #AGRESSIVEGROWTH #WORLDWIDE
Yep RXMD Awesome..!
Best green days are ahead my friends...
CEO's comments on CBD research and Mass Ventures from this morning's interview:
“We are also developing our products and services to meet the needs of the people, who we communicate with through these platforms (developed by Mass Ventures), and so that’s where we made advancements in researching how we can use CBD, which is cannabis extract. We are making more strives and research in different dosage forms and methods of taking medication in our compounding department, different ways we can interact with our nursing home facilities, all based on interactions and engagement we have with the public through Mass Ventures, through our social media, and through our website. So it’s very exciting. And we believe that how we improve our patient satisfaction and loyalty, and our investor satisfaction and our shareholder value. ”
Yep... BVTK GOLD will deliver...
$27 Million in revs for 2018 very acceptable.
And that may be conservative.
So you dont' have any proof to back up your statements about Steve do you..?
I don't see berd's posts anymore. Can you guess why..?
ONCI to 30 this morning... Should exceed that tommorrow...
Really..? So you have Steve's private posts..?
Please do post a few of those private posts here so we can see what you're referring to... Or did you make that up too..?
In Reply to 'zombywolf' on 'On4 Communications, Inc. (ONCI)
How about why is our Stevie abusing berd in private
Yeppers...
Read: RXMD is The Best Investment For 2018
RXMD One of America's Most Undervalued Stocks
https://askwarrenbuffet.blogspot.com/2018/02/the-best-investment-for-2018-is.html
The Best Stock Investment For 2018 Is Progressive Care (RXMD)
It is very rare to find a stock like Progressive Care (RXMD) trading at such a low level! Progressive Care (RXMD) is THE #1 stock to buy right now, one of the most undervalued stocks in America!
Currently trading at a deep discount under 10 cents a share, analysts believe the current fair value of the company should be over 50 cents plus a share!
Progressive Care (RXMD) has gone from generating $9 million in revenues in 2013 to $20 million in 2017, trouncing CVS, Walgreens and Rite-Aid average per store pharmacy revenues.
Progressive Care (RXMD) employs a highly successful business model of being a Healthcare Services and Technology company that provides excellent and affordable services while lowering the cost. With expansion plans across Florida and now licensed in 10 States Progressive Care (RXMD) is building a national brand!
As they expand, this will easily become a $100 million plus revenue company! Progressive Care (RXMD) will continue to gain efficiencies that will enhance the bottom line, and the share price is only going to keep rising! Along with the $20 million net revenue attained in 2017, Progressive Care (RXMD) is set to achieve the gold standard for allowing institutional funds to pour into the stock as they prepare to soon release their second consecutive year of audited financials.
Make no mistake about it, institutional investing is coming to Progressive Care (RXMD). If ever there was a time to buy shares, it is now, institutional investing is just one of the catalysts that will continue to propel Progressive Care (RXMD) share price much higher!
Online retailer Amazon, Berkshire Hathaway and JPMorgan Chase & Co. just announced that they will form an “independent company” to improve healthcare and lower costs for their hundreds of thousands of U.S. employees.
Progressive Care's (RXMD) incredibly successful pharmaceutical business model which delivers improved healthcare at lower costs is exactly what Amazon, Berkshire Hathaway and JPMorgan Chase & Co are striving for. Amazon's entry into the healthcare space has been rumored for months, with many observers speculating the e-commerce giant might expand into retail pharmacy and battle the likes of CVS Health and Walgreens Boots Alliance.
South Florida where Progressive Care (RXMD) is based, is a hotspot for the nationwide trend of small pharmaceutical/healthcare acquisitions in this sector. This gives even more added value to Progressive Care (RXMD) who are already two steps ahead of these big players now entering the pharmaceutical/healthcare market.
Progressive Care (RXMD) is well established and positioned to rival AMAZON to become potentially one of the largest online pharmacy and healthcare services companies!
Progressive Care (RXMD) has already confirmed they are actively looking at various merger and acquisition opportunities, so it will not come as a surprise to see a major player scoop up Progressive Care (RXMD), a cash flow positive, profitable and successful company.
As mentioned earlier, Progressive Care (RXMD) is blowing away the competition, their revenue is far superior when you compare the revenue per store of the current big 3 players.
Numbers don't lie, they are screaming that Progressive Care (RXMD) is a STRONG BUY NOW! Just look at how strong Progressive Care (RXMD) is, in fact even if you added all three of these nationwide chains per store average together Progressive Care (RXMD) easily beats them all combined! Take a look:
-CVS Pharmacy Revenues average of $8.5 million per store.
-Walgreens Pharmacy Revenues average of $6.6 million per store.
-Rite Aid's Pharmacy Revenues average of $4.2 million per store.
-Progressive Care (RXMD) revenues were $20.1M in 2017 and are forecast to bring in around $22-25 million this year EVEN without any expansion or merger or acquisition!
Progressive Care (RXMD) has one of the State of Florida's leading pharmaceutical compounders on it's staff allowing it to prepare medications tailored to meet individual patients needs.
Progressive Care (RXMD) is also in the forefront of researching the development and application of compounding Pharmaceutical and over the counter drugs based on Cannabis.
Progressive Care (RXMD) have a dedicated R&D department working on these products in house. Researchers have used their understanding of how the brain processes cannabinoids to develop drugs which follow the same pathways but work differently than marijuana. CBD, or cannabidiol, is a compound in marijuana that offers many benefits without any high.
On February 27th 2018, in an investor communication Progressive Care (RXMD) reported positive results on their CBD/Hemp Compound R&D product and stated they are now in talks with CBD manufacturers for future production needs. The company is very excited about this new revenue stream with good reason.
There is a huge ever growing market for their product. Forbes reported that the CBD market will grow to a $2.1 billion market in consumer sales by 2020. With this market growing in leaps and bounds Progressive Care (RXMD) revenues are forecast to skyrocket!
The added value here is that this product does not have to be in a prescription drug format, It can be sold in over the counter compound formula's allowing easier access to this type of product while generating huge new revenue streams for Progressive Care (RXMD).
CBD appears to be helpful for many health conditions, including epilepsy, anxiety, chronic pain, and more. Doctors are generally supportive of CBD because it has very few side effects
Clearly Progressive Care (RXMD) business model is setting the standard for the pharmaceutical and healthcare sector, once again CVS,Walgreens and Rite Aid don't even come close!
Progressive Care (RXMD) ALSO just reported they had broken another record, they announced a record breaking month for January 2018!
Progressive Care (RXMD) filled over 23,000 prescriptions during the month of January, generating $1.8 million in net revenues.
Prescriptions filled increased by 34% compared to the same month last year and by 10% over the last record breaking month in October 2017. Revenues increased by approximately 9% as compared to January 2017. The company also filled over $450,000 worth of prescriptions (not included in Net Revenues) for 340B entities in January, generating fees to the pharmacy of just over $20,000.
You're welcome my friend...
Let's keep this running green till we break .10 -.20
Then it's blue skies above...
$RXMD UPCOMING CATALYSTS / NEWS
Chicago Ventures Debt Payoff News: CV and any outstanding debt is most likely paid off now but waiting for confirmation. This will be HUGE news as all of their future financing will go traditional routes.
February Numbers: Week of March 12th or 19th - should be record revenues again with possibly our second 2M+ month.
Audited Annual Report: April 4th or sooner
S. Parikh Mars, CEO of Progressive Care Inc., Discusses Recent RXMD News and Corporate Moves in a New Audio Interview with SmallCapVoice.com
GlobeNewswireMarch 1, 2018
AUSTIN, Texas, March 01, 2018 (GLOBE NEWSWIRE) -- SmallCapVoice.com, Inc. (SCV) and Progressive Care Inc. (RXMD), a healthcare services and technology company, today announced that a new audio interview with the Company is now available. The interview can be heard at https://smallcapvoice.com/blog/2-28-18-smallcapvoice-interview-with-progressive-care-inc-rxmd.
S. Parikh Mars, CEO of Progressive Care Inc. called in to SmallCapVoice.com, Inc. to discuss the recent news and achievements for the Company. So far in 2018, Progressive Care announced that 23,000 prescriptions were filled during the month of January, generating $1.8 million in net revenues. That is record for the Company and up 34% from the same month in 2017. RXMD is also proud of the work they are accomplishing with Mass Ventures Corp, a Florida company, who has significantly enhanced the digital presence and technology solutions for the company and all subsidiaries. Other important achievements include the expansion into Palm Beach County and the news that its retail pharmacy will officially begin accepting Bitcoin payments.
In the interview, Ms. Mars was asked what she was excited about in 2018 for her Company and she stated, “I think the coolest thing that I am most excited about is our Telepharmacy platform. While it might be hard for someone who has not seen the software or hasn’t interacted with a kiosk yet to imagine how it works, essentially it allows the patient to go to the doctor, come out with a prescription, visit a convenient kiosk, interact directly with a pharmacy technician on the screen, and speak right to a pharmacist remotely and in real time. There is a face to face interaction with a pharmacist to handle any question or concern the patient has without ever having to visit the pharmacy and wait in line. The medication is then delivered directly to patient’s home. All of this is safe, secured through the software, and HIPAA compliant.”
About SmallCapVoice.com
SmallCapVoice.com is a recognized corporate investor relations firm, with clients nationwide, known for its ability to help emerging growth companies build a following among retail and institutional investors. SmallCapVoice.com utilizes its stock newsletter to feature its daily stock picks, audio interviews, as well as its clients' financial news releases. SmallCapVoice.com also offers individual investors all the tools they need to make informed decisions about the stocks they are interested in. Tools like stock charts, stock alerts, and Company Information Sheets can assist with investing in stocks that are traded on the OTC BB and Pink Sheets. To learn more about SmallCapVoice.com and their services, please visit http://smallcapvoice.com/blog/the-small-cap-daily-small-cap-newsletter/.
About Progressive Care
Progressive Care Inc. (RXMD), through its subsidiaries Smart Medical Alliance, Inc. and PharmCo, LLC, is a South Florida health services organization and provider of prescription pharmaceuticals, compounded medications, provider of tele-pharmacy services, the sale of anti-retroviral medications, medication therapy management (MTM), the supply of prescription medications to long term care facilities, administration and practice management, utilization management, quality assurance, EHR Implementation, billing and coding, and health practice risk management.
Get connected and stay in touch with us on social media:
Progressive Care Inc.
https://www.facebook.com/ProgressiveCareUS/
https://twitter.com/ProgressCareUS
PharmCo, LLC
https://www.facebook.com/pharmcorx/
https://twitter.com/PharmCoRx
Cautionary Statement Regarding Forward Looking Statements
Statements contained herein that are not based upon current or historical fact are forward-looking in nature and constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such forward-looking statements reflect the Company’s expectations about its future operating results, performance and opportunities that involve substantial risks and uncertainties. These statements include but are not limited to statements regarding the intended terms of the offering, closing of the offering and use of any proceeds from the offering. When used herein, the words “anticipate,” “believe,” “estimate,” “upcoming,” “plan,” “target,” “intend” and “expect” and similar expressions, as they relate to Progressive Care Inc., its subsidiaries, or its management, are intended to identify such forward-looking statements. These forward-looking statements are based on information currently available to the Company and are subject to a number of risks, uncertainties, and other factors that could cause the Company's actual results, performance, prospects, and opportunities to differ materially from those expressed in, or implied by, these forward-looking statements.
Contact:
Armen Karapetyan
Senior Advisor Business Development
armen@progressivecareus.com
www.progressivecareus.com
www.pharmcopharmacy.com
For SmallCapVoice.com
Stuart T. Smith
512-267-2430
info@smallcapvoice.com
Progressive Care Inc.
901 N Miami Beach Blvd
Suite 1-2
North Miami Beach, FL 33162
SOURCE
Excellent Update my friends..!
S. Parikh Mars, CEO of Progressive Care Inc., Discusses Recent RXMD News and Corporate Moves in a New Audio Interview with SmallCapVoice.com
GlobeNewswire March 1, 2018
AUSTIN, Texas, March 01, 2018 (GLOBE NEWSWIRE) -- SmallCapVoice.com, Inc. (SCV) and Progressive Care Inc. (RXMD), a healthcare services and technology company, today announced that a new audio interview with the Company is now available. The interview can be heard at https://smallcapvoice.com/blog/2-28-18-smallcapvoice-interview-with-progressive-care-inc-rxmd.
S. Parikh Mars, CEO of Progressive Care Inc. called in to SmallCapVoice.com, Inc. to discuss the recent news and achievements for the Company. So far in 2018, Progressive Care announced that 23,000 prescriptions were filled during the month of January, generating $1.8 million in net revenues. That is record for the Company and up 34% from the same month in 2017. RXMD is also proud of the work they are accomplishing with Mass Ventures Corp, a Florida company, who has significantly enhanced the digital presence and technology solutions for the company and all subsidiaries. Other important achievements include the expansion into Palm Beach County and the news that its retail pharmacy will officially begin accepting Bitcoin payments.
In the interview, Ms. Mars was asked what she was excited about in 2018 for her Company and she stated, “I think the coolest thing that I am most excited about is our Telepharmacy platform. While it might be hard for someone who has not seen the software or hasn’t interacted with a kiosk yet to imagine how it works, essentially it allows the patient to go to the doctor, come out with a prescription, visit a convenient kiosk, interact directly with a pharmacy technician on the screen, and speak right to a pharmacist remotely and in real time. There is a face to face interaction with a pharmacist to handle any question or concern the patient has without ever having to visit the pharmacy and wait in line. The medication is then delivered directly to patient’s home. All of this is safe, secured through the software, and HIPAA compliant.”
About SmallCapVoice.com
SmallCapVoice.com is a recognized corporate investor relations firm, with clients nationwide, known for its ability to help emerging growth companies build a following among retail and institutional investors. SmallCapVoice.com utilizes its stock newsletter to feature its daily stock picks, audio interviews, as well as its clients' financial news releases. SmallCapVoice.com also offers individual investors all the tools they need to make informed decisions about the stocks they are interested in. Tools like stock charts, stock alerts, and Company Information Sheets can assist with investing in stocks that are traded on the OTC BB and Pink Sheets. To learn more about SmallCapVoice.com and their services, please visit http://smallcapvoice.com/blog/the-small-cap-daily-small-cap-newsletter/.
About Progressive Care
Progressive Care Inc. (RXMD), through its subsidiaries Smart Medical Alliance, Inc. and PharmCo, LLC, is a South Florida health services organization and provider of prescription pharmaceuticals, compounded medications, provider of tele-pharmacy services, the sale of anti-retroviral medications, medication therapy management (MTM), the supply of prescription medications to long term care facilities, administration and practice management, utilization management, quality assurance, EHR Implementation, billing and coding, and health practice risk management.
Get connected and stay in touch with us on social media:
Progressive Care Inc.
https://www.facebook.com/ProgressiveCareUS/
https://twitter.com/ProgressCareUS
PharmCo, LLC
https://www.facebook.com/pharmcorx/
https://twitter.com/PharmCoRx
Cautionary Statement Regarding Forward Looking Statements
Statements contained herein that are not based upon current or historical fact are forward-looking in nature and constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such forward-looking statements reflect the Company’s expectations about its future operating results, performance and opportunities that involve substantial risks and uncertainties. These statements include but are not limited to statements regarding the intended terms of the offering, closing of the offering and use of any proceeds from the offering. When used herein, the words “anticipate,” “believe,” “estimate,” “upcoming,” “plan,” “target,” “intend” and “expect” and similar expressions, as they relate to Progressive Care Inc., its subsidiaries, or its management, are intended to identify such forward-looking statements. These forward-looking statements are based on information currently available to the Company and are subject to a number of risks, uncertainties, and other factors that could cause the Company's actual results, performance, prospects, and opportunities to differ materially from those expressed in, or implied by, these forward-looking statements.
Contact:
Armen Karapetyan
Senior Advisor Business Development
armen@progressivecareus.com
www.progressivecareus.com
www.pharmcopharmacy.com
For SmallCapVoice.com
Stuart T. Smith
512-267-2430
info@smallcapvoice.com
Progressive Care Inc.
901 N Miami Beach Blvd
Suite 1-2
North Miami Beach, FL 33162
SOURCE
So I guess you can't read either eh zomby..?
Looking at it right now.
https://backend.otcmarkets.com/otcapi/company/financial-report/179541/content
Page 20, halfway down.
Figures you'd be living in the past...
You know, there have been quite a few investors in OTTV who have invested since then and are in the green right..?
OTTV up 46+% today...
This is just the start of the green rush for OTTV.
We shall see...
Well the market just doesn't agree with you my friend...
OTTV up 46+% today...
Just the start of something BIG I'd say...
Yep...
2,000 subscribers @$35 is over $70,000 in monthly revenue that will soon be showing on the financials. This is recurring revenue that will continue to increase incrementally with increased subs. I like the future here! OTTV GOLD..!
Yep... Do it today folks...
Always, always, always set a high price when you post sell order on RXMD after you buy..!
My sell price is $2.88 for 2018.
In Reply to 'stockforce' on 'Progressive Care, Inc. (RXMD)
RXMD IS THE REAL GEM. This stock has been severely undervalued for years due to several reasons:
1. Progressive restructured its management team back in Jan. 2013 and got engaged in a 3(a)10 transaction for debt settlement in 2014, which helped them successfully pay off all the debt in Nov. 2015. They actually already had tremendous amount of revenues in those three years with double digit growth:
2013 net revenue: $9.33M
2014 net revenue: $11.27M
2015 net revenue: $13.64M
2. They completed their first audited financials of 2016 in April 2017. For the whole year of 2016, The stock price never surpassed 5 cents due to lack of audit and insufficient exposure to mass investors. See more DD of RXMD from INSTATRADER here:
https://investorshub.advfn.com/INSTATRADERS-LONG-TERM-OTC-WINNERS!!!!-32023/
3. The company started devoting more time and money on investors conferences and PR companies in 2017 after they made enormous achievements in their 2016 and 2017 revenue growth:
2015 net revenue: $13.64M
2016 net revenue: $18.32M
2017 net revenue: $20.1M
However, as the management said, institutional money would not start investing until they see at least 2 years of audits. The stock was still mostly unknown to mass investors at that time.
One of the biggest things the company is doing right now is to complete a second year audit of 2017. This is definitely a big GO for institutions and private equities, who normally have great investing interest in companies that have at least $20M revenue. The past week's price action was a clear indication to me that some institutional money started getting in with constant ask slaps and strong bid supports that were worth several million dollars.
Some other exciting things to expect this year, most likely within next several months are:
One or two M&A as a vehicle to help the company eventually uplist to NASDAQ. In CEO's own words from Uptick Newswire's interview on Feb 1, 2018:
Question - "Are you guys thinking about moving up to the NASDAQ?"
CEO, Shital Mars: "Yes. So the ultimate goal has always been to become fully SEC reporting and list on NASDAQ. We think that is the right place and right path for us to go. And we think healthcare is ripe for that change and we think there’s a lot of competition and opportunity in the marketplace for a company like ours to create something special and unique and worthy of being on NASDAQ. We also know that we want to have the right vehicle for it. So it’s not something we want to do just as we are today. We want to evolve into that NASDAQ worthy company, and we are putting all the staff in place, all the factors, all the personnel and resources in place right now to get us to there as our end goal."
Entry into CBD/Hemp Market
Acquiring additional 12 out-of-state licenses, which will make them obtain a total 29 state licenses in the U.S. by EOY.
The following are our strategic goals for 2018:
Achieve 25,000 prescriptions filled in a single month by December 2018
Increase annual overall sales to $22 million
Secure additional 340B contracts and long term care facility relationships
Further expansion into Palm Beach County
Achieve accreditation for non-sterile compounding
Achieve full enterprise profitability and earnings growth
Publish 2nd year of audited financial statements and leverage these statements to secure new investment opportunities for mergers and acquisitions
Opening more Pharmco Pharmacy Resource Centers in retirement and long term care communities.
Strengthening our tele-pharmacy platform
Closing Remarks
The strength of Progressive Care has always been in the hands of its employees and its shareholders. Without the loyalty and dedication of both, this Company would not be where it is today. We have thrived because of the unyielding support in the face of immense challenges and we know that we must never waver in our desire to always earn the trust that has been bestowed upon us. Thank you to all who believe in us and we look forward to delivering another phenomenal year.
Just for your fun reading, I have compiled a short version of Progressive's long history since its inception in 2006 and even before that all the way to 1997. This company is indeed a GEM that has just been noticed by BIG money. Get in now and we will witness how this stock will make its way all the way to NASDAQ.
A short version of ProgressiveCare's long history:
Everything started from a person called Buddy Young. He founded a publicly traded company called Web Star Training in 1997, engaging in the development, production, and distribution of training and educational video products and services. The company then changed its name to Advanced Knowledge, Inc. in 2000; and to Advanced Media, Inc. in 2003. Later, the company changed its name to Advanced Media Training, Inc. in 2004. Advanced Media Training is based in Encino, California. As of December 11, 2006, Advanced Media Training, Inc. was acquired by Dematco Corporation, a private UK company, in a reverse merger.
Progressive Training Inc. was incorporated by Mr. Young in Delaware on October 31, 2006. From the date it was incorporated until March 1, 2007, it was a wholly owned subsidiary of Dematco, Inc. On March 1, 2007, to facilitate Dematco's exit from the training business, Progressive Training acquired all of Dematco's assets and liabilities related to the production and distribution of workforce training videos.
In 2006, another person, Avraham A. Friedman, together with two partners, founded Pharmco in Florida. Mr. Friedman started in 1996 at the clerk level and after 4 years in 2000 became retail manager for a busy New York City independent pharmacy. He then left New York for Florida and started Pharmco in 2006.
Then, on October 21, 2010, Progressive Training, Inc. entered into an Agreement and Plan of Reverse Merger with Pharmco Corp. Upon the closing of the Exchange, Buddy Young resigned as the Company’s sole officer and director and David Leedy, Dennis Spiegelman and Mel Powell resigned from their positions as members of the Company’s board of directors. Simultaneously with the effectiveness of the Merger a new board of directors and new officers were appointed. The new board of directors consists of Avraham A. Friedman, Andy Subachan and Alan Jay Weisberg. Avraham A. Friedman was appointed as the Company’s Chief Executive Officer and President. Andy Subachan was appointed as the Company’s Chief Operating Officer. Alan Jay Weisberg was appointed as our Chief Financial Officer.
Mr. Weisberg is a Certified Public Accountant and currently operates Weisberg Brause & Co. Mr. Weisberg served as chief financial officer and as a director of QuickByte Software, Inc., from July 2008 to July 14, 2009. He served as chief financial officer and as a director of Getting Ready Corporation, Inc. from September 2007 through September 2008. From April 1998 through December 2006, Mr. Weisberg served as chief financial officer and as a director of Orthodontix, Inc. In addition, Mr. Weisberg served as chief financial officer and as a director of Protalix Biotehrapeutics, Inc. from December 2006 through April 2007. Mr. Weisberg also serves as a member of the board of directors and as secretary of Protech Global Holdings Corp. (“Protech”) Mr. Weisberg also previously served as chief financial officer of Protech.
On November 24, 2010, Progressive Training, Inc. (the “Company”) filed a Certificate of Ownership and Merger, pursuant to which its wholly-owned subsidiary, Progressive Care Inc. was merged into and with the Company (the “Merger”). In connection with the Merger, the Company changed its name to “Progressive Care Inc.”
Effective January 1, 2011, Mr. Young's another company, Futura Pictures, Inc. acquired from Progressive Training, Inc. all of its assets and liabilities related to Progressive’s workforce training business. On February 27, 2015, Mr. Young sold Futura Pictures to some South Korean guys and the company's name was changed to IMK Group, Inc.
On March 23, 2012, Progressive's CEO Avraham Friedman, issued his inaugural annual letter to the shareholders. The letter outlined Progressive Care's accomplishments in 2011 as well as its strategic goals and initiatives for 2012. Some highlights included hiring world renowned recording artist Luther Campbell as a company spokesperson. Mr. Campbell is deeply involved in the company's community outreach program and in the development of our anti-retroviral patient management program. Mr. Campbell's work will also be in combination with the new initiative planned by Progressive Care and PharmCo's HIV/AIDS Action Committee headed by Mrs. McDonald, a former Florida Department of Health Program Manager. They also have begun delivering with their fleet of visually branded delivery vehicles delivering to all of South Florida. The fleet is part of a marketing effort to enhance visibility of PharmCo in South Florida. They also signed an LOI to acquire an independent pharmacy in Coral Springs, FL.
On April 30, 2012, Progressive Care entered into the Equity Agreement with TCA. TCA committed to purchase up to $2,000,000 of the Company’s common stock for a period of twenty-four (24) months.
On August 30, 2012, Progressive Care announced that it has hired Mr. Vernon Watson as Chief Executive Officer and Ms. Shital Parikh Mars as Chief Operating Officer, effective August 27, 2012. Ms. Parikh was also appointed to the Board of Directors of Progressive Care at meeting held on August 24, 2012. Mr. Avraham Friedman, the Company’s former CEO, remained Chairman of the Board and assumed the role as the Company’s Chief Compliance Officer.
Mr. Watson was a Regional Sales Manager for MOMS Pharmacy in Melville, New York before joining Progressive. He helped increase the company’s sales and market share from New York to the tri-state area and Florida.
Ms. Parikh has been a vital consultant to the Company for the past three years (2009 - 2012). As President and CEO of Spark Financial Consulting, Ms. Parikh provided business development consulting services in which she advised the Company on human resources, financial reporting and transactions, operations, compliance, SEC filings, and investor relations, among other things. Ms. Parikh was also the Chief Operating Officer of Basis Financial, a boutique investment banking firm engaged by the Company. Her experience in the financial services industry centers on operational management, preparation and submission of financial statements, mergers & acquisitions, securities offerings, SEC reporting, due diligence, compliance, and regulatory audits. Ms. Parikh currently maintains 8 securities license registrations including the Series 7, Series 66, and Series 24.
On, January 17, 2013, Mr. Vernon Watson resigned from his position as the Chief Executive Officer of Progressive Care, Inc. after only five months with the company. His own words in the resignation letter: "Please accept this letter as my two-week notice of resignation. My last day of work will be Jan 25 th , 2013. It's been a wonderful 5 month experience working with Progressive Care. I have decided to relocate back to New York. I have enjoyed working with each and every one of you and appreciate the opportunities I've been given. I will do my best to hand off any current appointments prior to my last day of work. Please let me know if you need my help in any other way."
On January 21, 2013, Mr. Avraham Friedman resigned from his position as Chairman of the Board of Directors (the “Board”) of the Company. His own words in the resignation letter: "I thank each and every one of you for the opportunity to sit as Chairman of the Board. Regrettably, I must resign my position as Chairman of the Board effective immediately. I will, however, continue to retain my position as Chief Compliance Officer and look forward to working together to improve and grow Progressive Care. I thank you."
On January 22, 2013, the Board approved by unanimous written consent the appointment of Mr. Alan Jay Weisberg as the Company’s Interim Chief Executive Officer and Chairman of the Board. Mr. Weisberg has been a member of the Board and has served as Chief Financial Officer of the Company since October 2010.
On February 5, 2013, Mr. Avraham Friedman resigned from his position as Chief Compliance Officer of Progressive Care Inc. (the “Company”). In connection with Mr. Friedman’s resignation, the Company provided severance payment in the form of one half of Mr. Friedman’s current salary and one half of the premiums for Mr. Friedman’s insurance policy for a period of twenty-four weeks. His resignation letter:"This letter shall serve as notice that effective immediately, I hereby resign from my position as Chief Compliance Officer with Progressive Care, Inc. (the "Company", and all other positions to which I have been assigned, regardless of whether I served in such capacity, of the Company. The resignation is not the result of any disagreement with the Company on any matter relating to the Company's operations, policies or practices. Sincerely."
On May 17, 2013, the board of directors of Progressive Care, Inc. dismissed Berman & Co., P.A., as the Company’s independent registered public accounting firm. On the same day, the board approved the engagement of Mallah Furman, Certified Public Accountants (“Mallah”), as the Company’s new independent registered public accounting firm.
On September 3, 2014, the Circuit Court of the Second Judicial Circuit for Leon County, Florida approved the 3(a)(10) transaction between Progressive Care and Tarpon Bay Partners. Progressive and Tarpon reasonably estimated that the fair market value of the Settlement Shares, the Fee Shares (as defined below) and all other amounts received or to be received by Tarpon is equal to approximately $2,434,673.00.
On March 18, 2015, Progressive terminated 12g with SEC.
On Dec 29, 2014, COO, Shital Mars released an open letter to Shareholders. Highlights of 2014:
Agreement and court approval to execute a 3(a)(10) transaction through Tarpon Bay Partners, LLC to eliminate $1.8 million in debt in the coming year
Filed unaudited financial statements with OTCMarkets through the most recent completed quarter
Restructured Management
Aggressively cut costs
Began a hiring program to recruit talent and meet growing demand
Renovated our PhamCo facility
Increased filled prescription counts by approx. 50% from 8,500 scripts per month to almost 13,000
Increased pharmacy sales by 35% to $8.1 million through September 30, 2014
The strategic goals for 2015:
Increase filled prescription counts to 20,000 per month by December 2015
Increase annual overall sales to $15 million
Achieve full enterprise profitability
Eliminate approximately $1.8 million in debt from the balance sheet
Merge, acquire or otherwise align ourselves with a synergistic independent pharmacy to create economies of scale
On November 10, 2015, Progressive announced the fourth consecutive quarters of profitability for PharmCo, LLC. Through the first nine months of 2015, PharmCo, LLC has recorded nearly $350,000 in net income. This is a significant turnaround when compared to net losses of $114,000 for PharmCo during the same time period in 2014. PharmCo has recorded profits in every quarter for the past 12 months. Profitability and positive cash flow in PharmCo has been achieved through concentrated marketing efforts, expansion of the compounded medication department and month over month of net increases in prescription sales. Progressive Care's consolidated income was nearly break even in the third quarter when adjusted for stock based compensation of $147,000.
Due to dramatic increases in demand, PharmCo initiated plans to expand the pharmacy this quarter. The facility currently fills approximately 50,000 prescriptions per quarter with minimal square footage devoted to compounding and long term care operations. The expansion plan would nearly double the amount of general filling space plus expand the compounding department. The company also is in the process of choosing and purchasing a robotic dispensing system. This system will allow PharmCo to tremendously increase production and save on labor cost. To take advantage of its marketing capabilities the company plans to expand to Palm Beach County. PharmCo expects the expansion to produce numerous positive results including improvements to efficiency and capacity as well as increased revenues.
Recently, PharmCo began the process of establishing 340B sales. Both PharmCo and its 340B provider are installing the vendor data necessary to start purchasing inventory for 340B patients. The Company anticipates that we will be realizing sales in this area before the end of the year. PharmCo is also quickly increasing its footprint in the Medication Therapy Management (MTM) industry. On a monthly basis, the company is seeing increases in the number of MTM cases provided by Medicare plans. While the company does not expect a material impact on this year's sales from MTM cases, MTM will be an important part of the business in 2016.
On December 10, 2015, Progressive announced that it has completed its 3(a)(10) transaction. In total the company has issued 282,275,000 shares of common stock to eliminate over $1.9 million in aged debt off of its balance sheet. The company estimates that of these shares approximately 12,000,000 shares will be returned to treasury.
As of December 9, 2015, total common stock issued and outstanding was 352,043,045 shares. This number is net of a 1,718,000 share adjustment as these shares are beneficially owned by the company through PharmCo, LLC. The total number of shares that are not beneficially owned by insiders or affiliates was 306,833,938.
On Dec 14, 2015, Progressive announced record November pharmacy revenues. The pharmacy filled approximately 15,000 prescriptions during the month of November, which is nearly a 30% increase over the same month last year. Historically, due to the open enrollment window, physicians undergo major changes to their patient base resulting decreases in prescriptions written. However, PharmCo grossed approximately $1.3 million in net revenues for the month despite the lower prescription count. The compounding department continues to drive strong revenue growth.
In the week of Jan. 4, 2016, Progressive will issue 2016 Open Letter to shareholders.
In October, 2017, Progressive uplisted to OTCQB.
In Jan 2018, Progressive announced over $20M NET REVENUE for 2017.
In Feb 2018, Progressive announced all-time-high single month revenue of $2.25M and 23,000 prescription fills.
To be continued...
$ $RXMD
Right you are Doc...
Let's break 10 today...
Like I said, it touched the trendline, and, bounced back up.
T/A works here perfectly.
Now it is stronger than before, and, ready to break .10
Right you are Janet..!
OTTV GOLDEN...
OTTV- WE JUDGE THE FUTURE BASED ON THE PAST!!! - They Have been Successful and they will be Successful Again!!!.....
*** THE PAST IS GUARANTOR OF THE FUTURE***!!!
TRUST THE MANAGEMENT! They know best!!!
To refresh memory....From post #57024 by headsortails2066
The management is extremely experienced and well connected:
Johnny Falcones, Founder Chairman and CEO Viva Entertainment Group
- His extensive experience in the entertainment industry has guided the careers of Marc Anthony, Celia Cruz, Tito Puente and Soleil J, India, Ivy Queen & Jose Alberto "El Canario."
- He developed a successful record label with Universal Music and Video Distribution, turning it in to a multi-million dollar label.
- Falcones co-exec. produced the White House's 24th Annual Hispanic Heritage Awards in Sep. 2010, which featured a luminaries such Alejandro Sanz, Juan Luis Guerrera & Don Francisco.
Alberto Gomez President/Co-Founder, Viva Entertainment Group
- Mr. Gomez brings over 25 years of technical experience. He has proven success in marketing, advertising and engineering
- He developed multiple radio stations and systems for Radio Atlantica in Argentina
- He is an experienced leader in media and content negotiation, has thorough knowledge of pay television, its content and advertising in the South American countries of Argentina, Uruguay, Paraguay and Chile
John J Sepulveda Latin America President, Viva Entertainment Group
- A leader in the show business and entertainment industry. He has been a director, producer and promoter of the most important shows and concerts in the United States and South America during the last three decades
- He is an expert in developing alliances and successful association process with key industry individuals, promoters, service providers and private enterprise, deep knowledge of massive marketing within the Hispanic market
- John is also responsible for the developing and execution of the most important and high profile latino concerts in the United States in such venues as: Yankee Stadium, Citi Field Stadium, Madison Square Garden Arena, Radio City, Prudential Arena, Nassau Coliseum
Anthony Hernandez, Director, Viva Entertainment Group
- Currently serves as CEO for Oi2, which he Co-founded and built into the largest Spanish language radio network in the U.S. Oi2's current footprint spans throughout the digital space and across territorial broadcast and digital media presence in 33 countries via a network of 1,700+ radio station affiliations and digital distribution on mobile and satellite media platforms including iHeart Radio, TuneIn, SiriusXM Satellite Radio and more.
- Mr. Hernandez was a previous Hispanic media voice to Congressional Hispanic Caucus and FCC on advocacy for minority media interests
- During his tenure in media related efforts he has been able to work-in, develop, and manage various efforts in most communications disciplines: Broadcast & Satellite Television and Radio; Print; Online; Mobile Media; Grass-roots/Event Marketing, and much more. Launched over 23 of the most popular radio content brands in national Spanish radio (ie: EXA, NFL en Espanol, E! Entertainment en Espanol, Billboard Radio en Espanol, El Cucuy, El Chulo y La Bola, etc.).
Hector Marcano, Director, Viva Entertainment Group
- Mr. Marcano currently serves as Vice President of Hispanic Operations East, for iHeartMedia. Mr. Marcano has more than 30 years of experience in the media industry and as Vice President of Hispanic Operations East, Marcano works with iHeartMedia's Hispanic radio stations, with a special focus in the Miami, Chicago, Orlando and Atlanta markets
- Mr. Marcano is also responsible for creating innovative advertising opportunities based on iHeartMedia's unmatched national reach and local activation through its radio, digital and mobile assets, as well as its event capabilities, to provide Hispanic advertisers with targeted, effective, affordable and powerful ways to deliver their messages.
Just in the last couple months VIVA has:
- Reduced notes owed from $750k to $80k; could be $0 but shareholders are waiting for confirmation
- Brought their filings to CURRENT status
- Made their VIVA App available for download on Adroid and IOS and has achieved a couple thousand downloads just in the last 60 days
- Customer service has been just dynamite! Reacts quickly to questions and concerns.
- Soft launch has achieved around 250 paid subscriptions
- VIVAs App has hundreds of stations available now! Here are the channels:
//www.youtube.com/watch?v=SOEwh7qmH3M
TV-
Your right beer...
It looks like it's gonna break 10 today and I forgot about that 12+ projection by Friday. I'll stand with the 12+ projection by eod on Friday.
Thanks so much for reminding me...
Anybody care to make an educated guess as to RXMD pps by Friday..?
I'm gonna predict we break 10+ by Friday eod...
Great updates Stockforce...
Thanks so much...
UPDATES ON CONVERSATION WITH THE COMPANY - I called them at 11:50 am CST and spoke to Armen for about 30 minutes. They've got some great stuff ready to PR!
1. Chicago Venture Loan
CV is all DONE!! ACTUALLY he said it was done LONG TIME AGO!! Total $280K loan, they paid $130K in cash, and $150K in shares. All have been cleared. He thought they already PRed this. I was like what the heck!! Guess they have been so freaking busy these days that they even forgot to PR this great news! Zero debt, nothing, zip left!!! He will tell Shital to get the PR out tomorrow or asap.
2. M&A
He said they will have some updates coming out very soon. I asked about M&A, he said there will be update on that. I said when, he laughed in a way that says everything. I feel we will see a PR on this probably in March.
3. CBD/Hemp Compounds
He personally has tested their R&D product and thought it really worked very well. They are now in talks with CBD manufacturers for future production need. They will have dedicated R&D department working on these products in house. He's very excited about the huge market needs for their product. The good thing is this does not have to be prescription drugs. It can be over the counter compounds which will make it much easier for them to sell these products.
4. VIOSS Partner for Telepharmacy
They posted on their FB couple weeks ago saying VIOSS could be a potential partner for their telepharmacy business. Currently, they are actively testing VIOSS kiosks and other platforms and comparing to some other suppliers' products. They will pick the best one as their final partner going forward. Their plan is to put up telepharm kiosks in every major community center and long-term care facility that they are working with right now. That's really huge expansion.
5. 2017 Audit
Everything is all good. The audit will be complete by the due date on 3/31/2018. They will PR immediately after the due date or even before that next month.
6. Institutional Investment / Traditional Bank Financing
Now with 2 years of audit and over $20M NET revenue, he said institutions are finally willing to invest in them. They definitely will seek traditional bank financing going forward for their expansions and more M&A needs!
RXMD is golden. This is a great company with great leaders. 2018 HAS BEEN and WILL be GREAT for us all!
Great updates Stockforce...
Thanks so much...
UPDATES ON CONVERSATION WITH THE COMPANY - I called them at 11:50 am CST and spoke to Armen for about 30 minutes. They've got some great stuff ready to PR!
1. Chicago Venture Loan
CV is all DONE!! ACTUALLY he said it was done LONG TIME AGO!! Total $280K loan, they paid $130K in cash, and $150K in shares. All have been cleared. He thought they already PRed this. I was like what the heck!! Guess they have been so freaking busy these days that they even forgot to PR this great news! Zero debt, nothing, zip left!!! He will tell Shital to get the PR out tomorrow or asap.
2. M&A
He said they will have some updates coming out very soon. I asked about M&A, he said there will be update on that. I said when, he laughed in a way that says everything. I feel we will see a PR on this probably in March.
3. CBD/Hemp Compounds
He personally has tested their R&D product and thought it really worked very well. They are now in talks with CBD manufacturers for future production need. They will have dedicated R&D department working on these products in house. He's very excited about the huge market needs for their product. The good thing is this does not have to be prescription drugs. It can be over the counter compounds which will make it much easier for them to sell these products.
4. VIOSS Partner for Telepharmacy
They posted on their FB couple weeks ago saying VIOSS could be a potential partner for their telepharmacy business. Currently, they are actively testing VIOSS kiosks and other platforms and comparing to some other suppliers' products. They will pick the best one as their final partner going forward. Their plan is to put up telepharm kiosks in every major community center and long-term care facility that they are working with right now. That's really huge expansion.
5. 2017 Audit
Everything is all good. The audit will be complete by the due date on 3/31/2018. They will PR immediately after the due date or even before that next month.
6. Institutional Investment / Traditional Bank Financing
Now with 2 years of audit and over $20M NET revenue, he said institutions are finally willing to invest in them. They definitely will seek traditional bank financing going forward for their expansions and more M&A needs!
RXMD is golden. This is a great company with great leaders. 2018 HAS BEEN and WILL be GREAT for us all!